A Panel of Four miRNAs Accurately Differentiates Malignant from Benign Indeterminate Thyroid Lesions on Fine Needle Aspiration
- 1 April 2012
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 18 (7), 2032-2038
- https://doi.org/10.1158/1078-0432.ccr-11-2487
Abstract
Indeterminate thyroid lesions on fine needle aspiration (FNA) harbor malignancy in about 25% of cases. Hemi- or total thyroidectomy has, therefore, been routinely advocated for definitive diagnosis. In this study, we analyzed miRNA expression in indeterminate FNA samples and determined its prognostic effects on final pathologic diagnosis. A predictive model was derived using 29 ex vivo indeterminate thyroid lesions on FNA to differentiate malignant from benign tumors at a tertiary referral center and validated on an independent set of 72 prospectively collected in vivo FNA samples. Expression levels of miR-222, miR-328, miR-197, miR-21, miR-181a, and miR-146b were determined using reverse transcriptase PCR. A statistical model was developed using the support vector machine (SVM) approach. A SVM model with four miRNAs (miR-222, miR-328, miR-197, and miR-21) was initially estimated to have 86% predictive accuracy using cross-validation. When applied to the 72 independent in vivo validation samples, performance was actually better than predicted with a sensitivity of 100% and specificity of 86%, for a predictive accuracy of 90% in differentiating malignant from benign indeterminate lesions. When Hurthle cell lesions were excluded, overall accuracy improved to 97% with 100% sensitivity and 95% specificity. This study shows that that the expression of miR-222, miR-328, miR-197, and miR-21 combined in a predictive model is accurate at differentiating malignant from benign indeterminate thyroid lesions on FNA. These findings suggest that FNA miRNA analysis could be a useful adjunct in the management algorithm of patients with thyroid nodules.Keywords
Other Versions
This publication has 37 references indexed in Scilit:
- Expression Profiling of Difficult-to-diagnose Thyroid Histologic Subtypes Shows Distinct Expression Profiles and Identify Candidate Diagnostic microRNAsAnnals of Surgical Oncology, 2011
- Thyroid Hormone Receptor β (THRB) Is a Major Target Gene for MicroRNAs Deregulated in Papillary Thyroid Carcinoma (PTC)Journal of Clinical Endocrinology & Metabolism, 2011
- Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumoursBritish Journal of Cancer, 2009
- BRAF Mutation Testing of Thyroid Fine-Needle Aspiration Biopsy Specimens for Preoperative Risk Stratification in Papillary Thyroid CancerJournal of Clinical Oncology, 2009
- Molecular Testing for Mutations in Improving the Fine-Needle Aspiration Diagnosis of Thyroid NodulesJournal of Clinical Endocrinology & Metabolism, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Identification of Genes Differentially Expressed in Benign versus Malignant Thyroid TumorsClinical Cancer Research, 2008
- MicroRNA Expression Profiling of Thyroid Tumors: Biological Significance and Diagnostic UtilityJournal of Clinical Endocrinology & Metabolism, 2008
- The role of microRNAs in cancer: No small matterEuropean Journal of Cancer, 2007
- Functional Characterization of Human Thyroid Tissue with ImmunohistochemistryThyroid®, 2007